Inhibition of osteoblastic bone formation by nuclear factor-kappaB. - Wikidata - awgldk - TriplyDB

Inhibition of osteoblastic bone formation by nuclear factor-kappaB.

Inhibition of osteoblastic bone formation by nuclear factor-kappaB.

http://www.wikidata.org/entity/Q37401772

about

Mice with alopecia, osteoporosis, and systemic amyloidosis due to mutation in Zdhhc13, a gene coding for palmitoyl acyltransferase Regulation of gene expression in osteoblasts.Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia c-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16INK4a expression Ablation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in mice CD200 expression in human cultured bone marrow mesenchymal stem cells is induced by pro-osteogenic and pro-inflammatory cues Hydraulic Pressure during Fluid Flow Regulates Purinergic Signaling and Cytoskeleton Organization of Osteoblasts Accumulation of p100, a precursor of NF-κB2, enhances osteoblastic differentiation in vitro and bone formation in vivo in aly/aly mice.Antioxidant Effect of Fructus Ligustri Lucidi Aqueous Extract in Ovariectomized Rats Is Mediated through Nox4-ROS-NF-κB Pathway Osteoinductive LIM mineralization protein-1 suppresses activation of NF-kappaB and selectively regulates MAPK pathways in pre-osteoclasts.NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-κB.Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-κB.Oxidative stress stimulates apoptosis and activates NF-kappaB in osteoblastic cells via a PKCbeta/p66shc signaling cascade: counter regulation by estrogens or androgens.Cooperative role of NF-{kappa}B and poly(ADP-ribose) polymerase 1 (PARP-1) in the TNF-induced inhibition of PHEX expression in osteoblasts Oxytocin and bone Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.Enhancement of Flow-Induced AP-1 Gene Expression by Cyclosporin A Requires NFAT-Independent Signaling in Bone Cells.Altered microRNA expression profile in exosomes during osteogenic differentiation of human bone marrow-derived mesenchymal stem cells p62 is required for stem cell/progenitor retention through inhibition of IKK/NF-κB/Ccl4 signaling at the bone marrow macrophage-osteoblast niche.Novel functions for NFκB: inhibition of bone formation Constitutive activation of IKK2/NF-κB impairs osteogenesis and skeletal development.Inflammation and uncoupling as mechanisms of periodontal bone loss Local administration of IKK small molecule inhibitor may enhance fracture healing in osteoporosis patient Infection, inflammation, and bone regeneration: a paradoxical relationship NF-κB-Mediated Regulation of Osteoclastogenesis Role of NF-κB in the skeleton IKKβ in postnatal perichondrium remotely controls endochondral ossification of the growth plate through downregulation of MCP-5.Systemic transplantation of human adipose-derived stem cells stimulates bone repair by promoting osteoblast and osteoclast function.Toddaculin, Isolated from of Toddalia asiatica (L.) Lam., Inhibited Osteoclastogenesis in RAW 264 Cells and Enhanced Osteoblastogenesis in MC3T3-E1 Cells TGF-β mediates suppression of adipogenesis by estradiol through connective tissue growth factor induction Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice.Photodynamic activation as a molecular switch to promote osteoblast cell differentiation via AP-1 activation Pregnane X receptor knockout mice display osteopenia with reduced bone formation and enhanced bone resorption.NF-κB in Aging and Disease The current and future therapies of bone regeneration to repair bone defects.Diabetes aggravates periodontitis by limiting repair through enhanced inflammation.Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss.Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs.MicroRNA-200c Represses IL-6, IL-8, and CCL-5 Expression and Enhances Osteogenic Differentiation.

P2860

Q21563394-F8670489-E42E-41DA-8BA4-09F048799021 Q27691363-1DA88D7D-8286-4B28-92A3-735A9CEE9898 Q28117317-50B84923-6B9A-4BBC-A58E-B841C6F2D7CF Q28504995-0E486E73-BC56-4663-B949-C8CD7F9D64C5 Q28509403-5A5F95B6-FA29-42C7-9081-4DA2A812C1E2 Q28818511-F2144C42-E1FC-4B0D-A91A-0F4A4FE1974A Q33461851-70DF2CD0-5BB4-449D-B1D6-FAED7B33D382 Q33636652-7B93C3B7-63A1-4DCF-8A81-E365498927C6 Q33710878-F22010B2-BD4F-4E7A-8545-8E383B1A123E Q33788146-1515DA34-4CB6-4CDA-ABBE-F5B94A384D7A Q33808220-9268DC3C-1307-4D2B-B62A-A4925BAC0A97 Q34156626-487E49D1-30FC-4ADF-9190-09E2B4A48B3A Q34197265-9CE5BED3-9C7C-4096-A46D-7A3ECB3F58D6 Q34251323-70136C7B-A1AE-40A4-856E-00B0841C9559 Q34356431-2BD1380E-88A8-49F8-A62A-F4429FD4E3B2 Q34597741-BB487B31-AF2A-4BC6-932C-87BF5F0ACFD6 Q34606971-E5CFDC77-6380-47FC-991B-F1C09B0E2625 Q34632678-2F063D03-5FF9-44F1-84D1-5658430299B8 Q34682095-A3B8DF88-C2B5-44F6-84A0-1D9D55120A52 Q34777301-A59BBBF3-F4DD-4F88-8942-7B4133D7B2C7 Q34806538-91A0ED91-5B0E-4866-9AD4-C35BF7CE4A84 Q35117972-A20EA5C3-D60F-4F7E-836F-51E4AA54BDC3 Q35129179-BAD15479-E9E5-482D-8E9A-06661A179495 Q35173936-4188F8AB-28F0-4129-813D-8CA67E723FFE Q35205143-7425E6E5-C55D-407D-9F92-D530322D6AAB Q35260971-A5E12D3C-A8B3-450D-8C60-64946EAD4575 Q35347883-E7C271FA-16B8-46FE-99D8-BBC72F5AFFCC Q35349586-D863AB1B-F6FE-42FB-9F6F-4E8E6905E2F3 Q35377298-96C549F9-F109-4811-96D7-95AF3FEEB540 Q35636508-A3DE3236-8665-420A-9386-64D9E7FFDC99 Q35646069-D4530DD8-C7E2-4DF6-8916-9ABF2B4D17FB Q35646110-67F0E600-B015-4149-9DC3-AC9C77941C0F Q35747537-4AC99169-9F9F-4D4C-AAF8-321C8D37ECC2 Q35765627-A943BA74-9764-46E8-BBFD-C85FC7889D65 Q35806773-F20BAD2C-BE2E-46BD-BBDF-52DD4432E814 Q35852374-C6ACC6C0-6EC4-4397-9E83-BA8A92F314D4 Q35863800-F84D629B-C28F-43BF-8308-310AF8232EE2 Q36026720-6D7D01ED-75C3-43A5-8546-EF1A97793814 Q36084443-79F17071-45D3-4FBD-B20E-7BF4BA1DE6F3 Q36104859-C02243FF-C8A6-462F-913D-DE0D0107A8B2

P2860

Inhibition of osteoblastic bone formation by nuclear factor-kappaB.

http://www.wikidata.org/entity/Q37401772

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inhibition of osteoblastic bone formation by nuclear factor-kappaB.

@en

Inhibition of osteoblastic bone formation by nuclear factor-kappaB.

@nl

type

label

Inhibition of osteoblastic bone formation by nuclear factor-kappaB.

@en

Inhibition of osteoblastic bone formation by nuclear factor-kappaB.

@nl

prefLabel

Inhibition of osteoblastic bone formation by nuclear factor-kappaB.

@en

Inhibition of osteoblastic bone formation by nuclear factor-kappaB.

@nl

P1433

Q37401772-D1E75FC9-1F9E-4588-AB35-952826A19BD6

P1476

Q37401772-4090BA5E-E740-4D14-9901-AE4F90DC7B78

P2093

Q37401772-2136B7D0-14A5-457B-8D81-D5736BF994C0

Q37401772-3DFD76A8-1229-4FFB-AF8E-80209A15D800

Q37401772-5265CF6E-7DFE-4A08-9D5A-A3BCF2172DD0

Q37401772-53243CD5-ACAC-46AC-88C0-7799B0941AB9

Q37401772-8E57BAB9-3833-46F4-B2AC-CE190DC42EB7

Q37401772-99D84885-F2A6-490A-A6F1-2BDE98DD07FD

Q37401772-D14D0250-2547-4D28-9ADD-D3D4D1050068

Q37401772-DCC67AC5-D25C-4D05-8596-D52BF973F377

Q37401772-FCE21755-6D82-479C-9A6F-320CA7D3DBC5

P2860

Q37401772-0E38F8AD-73A0-4FF7-B9A4-C8C308A4491C

Q37401772-0F37AF7C-31CB-41AA-8837-76AC69300DAB

Q37401772-108B1ED5-FE65-472D-B7D9-BE9B6EC3214D

Q37401772-1D4B1D4D-1D43-4CC8-BED1-4E96D4497466

Q37401772-24319DDF-9962-4B74-B3AC-DDB2BE89080C

Q37401772-43D74DB4-0F3E-48D3-9A0B-80300B820EA9

Q37401772-44617E61-DA51-48E4-9963-D208698967CC

Q37401772-4A234E81-E82B-4827-8C2F-4DFF53AC11B1

Q37401772-4B04BBE5-AE10-4CE2-9038-CF6CB4106222

Q37401772-4F92EEFF-AC21-4DF6-88CB-B746F2BADD98

P2888

Q37401772-1F837C5B-A2C7-471E-BB38-16BA378D5955

P304

Q37401772-5C904335-DCB5-48F8-B7A5-BA6842A6452D

P31

Q37401772-FFAE74BC-C349-40A9-94B9-5BF5F52A897C

P356

Q37401772-E915932F-9EB0-4BD9-9FE4-2B8790B0F55E

P407

Q37401772-BE5C1F4E-A67C-411D-95D7-AFE1F2F4EF46

P433

Q37401772-2F417A7C-86C4-49D0-ADBE-39FB56B1E86F

P478

Q37401772-C7E755C9-929E-417D-B1AE-175E2E1323EF

P577

Q37401772-7658C1F7-5425-47F9-9BA6-09F3407FEA42

P5875

Q37401772-0569F510-A9C7-448C-8211-894906E11B48

P698

Q37401772-CE65CB09-597B-4AE2-845A-8652261E7A04

P932

Q37401772-10B157F2-9ACA-492D-9F77-D13BAB39A18A

P356

P1433

Nature Medicine

P1476

Inhibition of osteoblastic bone formation by nuclear factor-kappaB.

@en

P2093

Cun-Yu Wang

http://www.w3.org/2001/XMLSchema#string

Eric Tang

http://www.w3.org/2001/XMLSchema#string

Jia Chang

http://www.w3.org/2001/XMLSchema#string

Kunliang Guan

http://www.w3.org/2001/XMLSchema#string

Laurie McCauley

http://www.w3.org/2001/XMLSchema#string

Paul H Krebsbach

http://www.w3.org/2001/XMLSchema#string

Renny Franceschi

http://www.w3.org/2001/XMLSchema#string

Zhipeng Fan

http://www.w3.org/2001/XMLSchema#string

Zhuo Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha

NF-kappaB regulation in the immune system

Skeletal remodeling in health and disease

Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors

Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation

Missing pieces in the NF-kappaB puzzle

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

Genetic regulation of osteoclast development and function

P2888

P304

682-689

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.1954

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24433515

http://www.w3.org/2001/XMLSchema#string

P698

19448637

http://www.w3.org/2001/XMLSchema#string

P932

2768554

http://www.w3.org/2001/XMLSchema#string